Please assess the completion status of the following clinical trial:

Trial Title: Effects of Atorvastatin on Blood Pressure and Urinary Albumin Excretion

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* LDL-C\>130 or \>160 mg/dL (depending on the total risk according to the most recent recommendations25).~* no previous hypolipidemic medication~* ability to provide Informed Consent.~Exclusion Criteria:~* pregnancy or lactation~* myocardial infarction or unstable angina within the past 6 months~* heart failure NYHA class III-IV~* renal disease (SCr\>3 mg/dL or proteinuria\>3g/d)~* liver disease~* history of malignancy~* history of drug or alcohol abuse~* treatment with corticosteroids~* any other condition with poor prognosis~* inability to provide Informed Consent.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: ACTIVE_COMPARATOR): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).